← FDA DRUG APPROVALS

FDA ANDA · ANDA218829

OMEPRAZOLE 20 MG

Sponsor: MARKSANS PHARMA

APPLICATION
ANDA218829
TYPE
ANDA
ORIGINAL APPROVAL
2025-08-07
LATEST ACTION
2026-06-29
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Over-the-counter

Products

OMEPRAZOLE MAGNESIUMOver-the-counter
OMEPRAZOLE MAGNESIUM EQ 20MG BASE · TABLET, DELAYED RELEASE · ORAL

Approval history

2026-06-29Manufacturing (CMC) · Supplement 2 · unknownAP
2025-08-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →